Pledpharma AB shares now on First North at NASDAQ OMX Stockholm
Pledpharma AB (short name: PLED) shares will commence today, April
7, on First North at NASDAQ OMX Stockholm. Pledpharma belongs to
the Health Care sector.
Pledpharma develops therapies for severe diseases. By streamlining
the different treatments the company's drugs are designed to reduce
serious side effects while increasing patient survival rates.
Pledpharma currently has two projects in clinical Phase II, one in
the cancer field and one in the cardiovascular field.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, "We are
pleased that Pledpharma chose to list at First North, one of
Europe's most liquid growth markets, where they will make a great
addition to our healthcare sector. We continue to see a steady
listing inflow to First North and welcome more companies to take
advantage of the investor visibility and reach that we can
Pledpharma's CEO, Jacques Näsström, commented, "Today marks an
exciting day for our company and we look forward to benefiting from
the increased investor exposure at First North. Pledpharma operates
in a market with tremendous potential, and on First North we are
able to build the capital strength needed to support continued and
Pledpharma has appointed Erik Penser Aktiebolag as Certified
Read more about NASDAQ OMX